Other Clinical Trial - EFFECT OF TREADMILL TRAINING ON BALANCE AFTER

Status Completed

Clinical Trial Summary

Purpose: The present research was conducted to study the effect of treadmill training on balance after chemotherapy in children with acute lymphoblastic leukemia. Subjects and Methods: Forty children with acute lymphoblastic leukemia included in the current research ranged of age from 8 to 12 years. The children participated in this study were assigned randomly into two equal number groups (A and B). Group (A) includes 20 children who received balance exercises, while group (B) includes 20 children who received the same balance exercises of group (A) and treadmill training. The treatment program was applied three sessions per week (60 min for every session) for 8 weeks. Balance Master System and Biodex Balance System were used to evaluate balance of all children in the three groups before and after the treatment program.

Clinical Trial Description

The current research is a randomized control trial to differentiate between the treadmill training on balance after chemotherapy in children with acute lymphoblastic leukemia. Chemotherapy induced peripheral neuropathy is related to the intensity of treatment and dosage of chemotherapy which could affect the severity of its symptoms, it could result in serious problems like sensory changes and numbness , in case the sensory nerves were affected , muscle weakness and in-coordination in case the affected were the motor nerves. In addition to the psychological problems the patient experience as a result of CIPN, the patient also experience physical problems like injuries, fear of fall results from lack of sensory perception and muscle power. Treadmill training, motor training may favor proprioceptive feedback, leading to adjustments for adequate postural balance and functional performance. Treadmill exercises stimulate the kinetic, kinematic, and temporal features of walking. These exercises improve the strength of the muscles of the lower extremities, enhance motor learning, improve functional abilities, and activate the locomotor control system ;

Study Design

Related Conditions & MeSH terms

Acute Lymphoblastic Leukemia, Pediatric
Leukemia
Leukemia, Lymphoid
Precursor Cell Lymphoblastic Leukemia-Lymphoma

Clinical Trial Details

NCT number	NCT05032716
Study type	Interventional
Source	Cairo University
Contact
Status	Completed
Phase	N/A
Start date	May 5, 2021
Completion date	August 21, 2021

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03676504` - Treatment of Patients With Relapsed or Refractory CD19+ Lymphoid Disease With T Cells Expressing a Third-generation CAR	Phase 1/Phase 2
Enrolling by invitation	`NCT05622682` - Vaccine Immune Recovery After Leukemia
Not yet recruiting	`NCT05029531` - Combined Immuno-chemotherapy for Patients With B-linear Acute Lymphoblastic Leukemia Diagnosed From 0 to 365 Days of Life (ALL-Baby-2021)	Phase 3
Not yet recruiting	`NCT06107478` - Parental Perception of Their Child's Emotional Quality of Life in Paediatric Oncology Before and After "Magic Massages"
Recruiting	`NCT05809284` - Determining the Mechanisms of Loss of CAR T Cell Persistence
Recruiting	`NCT04049383` - CAR-20/19-T Cells in Patients With Relapsed/Refractory B Cell ALL	Phase 1
Active, not recruiting	`NCT04472286` - Healthy Bones, Healthy Life: Habitual Physical Activity on Bone & Metabolic Health in Pediatric Cancer Survivors
Completed	`NCT05973032` - MRD Detection by NGS in Pediatric B-ALL
Recruiting	`NCT03035344` - Study of the Intermediate Metabolism in Children With Acute Lymphoblastic Leukemia (ALL)	N/A
Terminated	`NCT03705507` - International Trial of Selumetinib in Combination With Dexamethasone for the Treatment of Acute Lymphoblastic Leukaemia	Phase 1/Phase 2
Recruiting	`NCT04325841` - Phase II Study of Anti-CD19 CAR-T Cells Treating Leukemia Children	Phase 2
Active, not recruiting	`NCT03020030` - Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents	Phase 3
Not yet recruiting	`NCT06257394` - Treatment of Pediatric Very High-risk Acute Lymphoblastic Leukemia in Korea	Phase 2
Active, not recruiting	`NCT03157323` - Low GI Diet in Children and Adolescents With ALL	N/A
Recruiting	`NCT04996160` - Palbociclib in Combination With Chemotherapy in Pediatric Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia (RELPALL2)	Phase 1
Not yet recruiting	`NCT06421155` - Brain MRF in Children, Adolescents and Young Adults With Acute Leukemia	N/A
Recruiting	`NCT03643276` - Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM ALL 2017	Phase 3
Recruiting	`NCT06074666` - Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence: Study 3	N/A
Active, not recruiting	`NCT04088864` - CD22-CAR T Cells in Children and Young Adults With B Cell Malignancies	Phase 1
Completed	`NCT04770922` - Pharmacogenomic Analysis in Pediatric Acute Lymphoblastic Leukemia

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

EFFECT OF TREADMILL TRAINING ON BALANCE AFTER CHEMOTHERAPY IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms